| CARD ID | 2094 | |
| Type of strain | Targeted mutant. | |
| Strain name | B6;129-L3mbtl3tm1Tmiy | |
| Internal Code | MBT-1+/- | |
| Submitter | Miyazaki Toru | |
| Submitter affiliation or code | Lab of Molecular Biomedicine for Pathogenesis, Center for Disease Biology and Integrative Medicine (CDBIM), The University of Tokyo | |
| Stock Type | ||
| Material Transfer Conditions |
Consent to us
|
|
| Production method | in-house breeding | |
| Origin (In-house) | Organization | The University of Tokyo |
| Organization code | Tmiy | |
| Developer | Toru Miyazaki | |
| Origin (From other organizations) | Organization | |
| Organization code | ||
| Developer | ||
| Year introduced | ||
| Introduced Generation | ||
| Remarks | ||
| Gene symbol | L3mbtl3(synonym: MBT-1) |
| Gene name | l(3)mbt-like 3 (Drosophila) |
| Allele symbol | L3mbtl3tm1Tmiy |
| Allele name | l(3)mbt-like 3 (Drosophila), targeted mutation 1, Toru Miyazaki, the University of Tokyo |
| MGI | MGI:2143628, |
| Chromosome | 10 (13.67) (10A4) , |
| Gene classification | Targeted or trapped gene(knockout etc.) |
| Method | Electroporation |
| OMIM |
| MBT-1 F | ATC CCG TCA GGC TTT CGA GTT GGG |
| MBT-1 R | ATC CTC CTG CAC CAC CTC CTA AGA |
| RV13 | GTA TCC ATC ATG GCT GAT GCA A |
| RV14 | AAC GCT ATG TCC TGA TAG CGG T |
| Disease name, Applicable field | Development, Immunology, cancer |